A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
High-Throughput Gene-Editing via Microfluidic Cell Deformability to Enable Off-the-Shelf Allogeneic Cellular Immunotherapies |
University of California, Los Angeles / Steven Jonas, MD/PhD |
Young Investigator Grants |
2017 |
California |
Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy |
Fred Hutchinson Cancer Research Center / Colin Godwin, MD |
Young Investigator Grants |
2018 |
Washington |
PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia |
Massachusetts General Hospital / Jessica Blackburn, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
APOBEC3 in Pediatric Leukemia: a Biomarker for Sensitivity to PARP Inhibition? |
Children’s Hospital of Philadelphia / Abby Green, MD |
Young Investigator Grants |
2014 |
Pennsylvania |
Using zebrafish to model the molecular origins of pediatric myeloid malignancies and acute myeloid leukemia |
Dana-Farber Cancer Institute / Evisa Gjini |
Young Investigator Grants |
2011 |
Massachusetts |
Genetic Dissection of Cancer Drug Resistance and Toxicity Using Haploid Human Cells |
Stanford University / Ramin Dubey, PhD |
Young Investigator Grants |
2015 |
California |
Mechanisms of regulation of the PI#K/AKT pathway downstream of NOTCH1 in T-ALL.
|
Columbia University / Teresa Palomero, PhD |
Young Investigator Grants |
2007 |
New York |
Epigenomic Mechanisms of Neuroblastoma Tumorigenesis |
Children’s Hospital of Philadelphia / Jo Lynne Harenza, PhD |
Young Investigator Grants |
2017 |
Pennsylvania |
Micro-environmental Regulators of Ewing sarcoma Metastasis |
University of Pittsburgh / Kelly Bailey, MD/PhD |
Young Investigator Grants |
2016 |
Pennsylvania |